PEPTIDESTER, VERFAHREN ZUR HERSTELLUNG DERSELBEN UND DIESE ENTHALTENDE ARZNEIMITTEL BEZIEHUNGSWEISE DIAGNOSTICA

New octapeptides of the general formula (I), X-Arg-Val-Tyr-Ile-His-Pro-Y-OA (I) wherein X stands for the acyl group of an N-methylamino acid or the acyl group of an aliphatic alpha -hydroxy- or alpha -aminooxycarboxylic acid, Y is the residue of an aliphatic amino acid, and A is a C1-5 alkyl group,...

Full description

Saved in:
Bibliographic Details
Main Authors SZPORNY, LASZLO, KARPATI, EGON, NYEKI, OLGA, KISFALUDY, LAJOS
Format Patent
LanguageGerman
Published 15.06.1985
Edition4
Subjects
Online AccessGet full text

Cover

Loading…
Abstract New octapeptides of the general formula (I), X-Arg-Val-Tyr-Ile-His-Pro-Y-OA (I) wherein X stands for the acyl group of an N-methylamino acid or the acyl group of an aliphatic alpha -hydroxy- or alpha -aminooxycarboxylic acid, Y is the residue of an aliphatic amino acid, and A is a C1-5 alkyl group, are prepared so that the protecting groups of a protected octapeptide derivative of the general formula (II), B-X-Arg(C)-Val-Tyr(D)-Ile-His(E)-Pro-Y-OA (II) wherein B is a group removable by acidolysis or catalytic hydrogenation, C is a group for the temporary protection of the guanidino group on the Arg moiety, D is a group for the temporary protection of the aromatic hydroxy group on the Tyr moiety, E is a group for the temporary protection of the imidazole group on the His moiety, and A, X and Y are as defined above, are removed either stepwise or in a single step. If desired, a compound of the general formula (I) is converted into its acid addition salt or pharmaceutically acceptable complex. The new compounds according to the invention possess angiotensin-II antagonizing effects, and can be used in the therapy to diagnose or treat hypertensive states.
AbstractList New octapeptides of the general formula (I), X-Arg-Val-Tyr-Ile-His-Pro-Y-OA (I) wherein X stands for the acyl group of an N-methylamino acid or the acyl group of an aliphatic alpha -hydroxy- or alpha -aminooxycarboxylic acid, Y is the residue of an aliphatic amino acid, and A is a C1-5 alkyl group, are prepared so that the protecting groups of a protected octapeptide derivative of the general formula (II), B-X-Arg(C)-Val-Tyr(D)-Ile-His(E)-Pro-Y-OA (II) wherein B is a group removable by acidolysis or catalytic hydrogenation, C is a group for the temporary protection of the guanidino group on the Arg moiety, D is a group for the temporary protection of the aromatic hydroxy group on the Tyr moiety, E is a group for the temporary protection of the imidazole group on the His moiety, and A, X and Y are as defined above, are removed either stepwise or in a single step. If desired, a compound of the general formula (I) is converted into its acid addition salt or pharmaceutically acceptable complex. The new compounds according to the invention possess angiotensin-II antagonizing effects, and can be used in the therapy to diagnose or treat hypertensive states.
Author KARPATI, EGON
NYEKI, OLGA
SZPORNY, LASZLO
KISFALUDY, LAJOS
Author_xml – fullname: SZPORNY, LASZLO
– fullname: KARPATI, EGON
– fullname: NYEKI, OLGA
– fullname: KISFALUDY, LAJOS
BookMark eNqNi00KwjAUhLPQhX93eAdQsFRwnTbTJhCjJK8K3ZQicSVtod4fs_AArmaY-b61WAzjEFdivOHGRiEw_J7u8JXUHo7axpOGT7O1jatJpQ5bpKdxipRBAMGxlpbhFEj61sFcDCeBCrQGOmnhAZNAZWTtroFNKbdi-erfc9z9ciOoApf6EKexi_PUP-MQP51kZPn5dGTO8j-QL_88OhY
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 4
ExternalDocumentID ATE13740TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_ATE13740TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:30:19 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ATE13740TT13
Notes Application Number: AT19810100356T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19850615&DB=EPODOC&CC=AT&NR=E13740T1
ParticipantIDs epo_espacenet_ATE13740TT1
PublicationCentury 1900
PublicationDate 19850615
PublicationDateYYYYMMDD 1985-06-15
PublicationDate_xml – month: 06
  year: 1985
  text: 19850615
  day: 15
PublicationDecade 1980
PublicationYear 1985
RelatedCompanies RICHTER GEDEON VEGYESZETI GYAR R.T
RelatedCompanies_xml – name: RICHTER GEDEON VEGYESZETI GYAR R.T
Score 2.3708565
Snippet New octapeptides of the general formula (I), X-Arg-Val-Tyr-Ile-His-Pro-Y-OA (I) wherein X stands for the acyl group of an N-methylamino acid or the acyl group...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PEPTIDESTER, VERFAHREN ZUR HERSTELLUNG DERSELBEN UND DIESE ENTHALTENDE ARZNEIMITTEL BEZIEHUNGSWEISE DIAGNOSTICA
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19850615&DB=EPODOC&locale=&CC=AT&NR=E13740T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDI6mgYAbDBDjpRxQT1T0tRYOFerDXYtKVnXpmHaZ1rQTXLaJFfH3cct4XOAWOXGUWPpsJ7EdQq7mSj4zhG7JlqbdyYYwFHlW6rl8q5fCLOaaIcomQJaZYWY8jHvjFnn-yoVp6oS-N8UREVEC8V41-nr1c4nlN7GV65v8BUnL-4DbvlR8povV5dfUnuS7NiQDf-BJnmc7XGKpDapuGQrHc9IWOtFWjQUYuXVOyuq3QQn2yXaCcy2qA9Iqyg7Z9b7-XeuQncfNczc2N8hbH5JlAgmPfBii-3lNR5AGTpgCo5MspSGkSI7jjPVpnTIAsYs9GfNp7ewBBcZDJ-bAfKBOOmFQKyxkoC5MIgiRbfgEEQ70I6fPBkMeec4RoQFwL5Rx5dNvIU0dvtkiV_Vj0l4sF-UJobqGihW9HFEowhBKb2aqc3Om5AViNbeE1SXdP6c5_afvjOzV0q5jptTeOWlXr2_lBVrnKr9sBPsB1OONkA
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDI6mgRg3GCDGMwe0ExV9bYVDhbrWXQtdVnXpmHaZ2rQTXLaJFfH3cct4XOAWOXGUWPpsJ7EdQq7mcproQjMkQ1XvJF3ospTkWirdarnoZnNVF3kVIMu6Xqw_TDqTGnn-yoWp6oS-V8UREVEC8V5U-nr1c4nlVLGV65v0BUnLe5ebTjv7TBcry68pnbbTMyEcOkO7bdumxdssMkHRDF3meE7aQgfbKLEA416Zk7L6bVDcPbId4lyLYp_UsrxJGvbXv2tNsjPYPHdjc4O89QFZhhBy34ERup_XdAyRa3kRMDqNI-pBhOQgiFmflikDEPSwJ2YOLZ09oMC4ZwUcmAPUiqYMSoWFDLQHUx88ZBs9gY8DHd_qs-GI-7Z1SKgL3PYkXPnsW0gzi2-2yBXtiNQXy0V-TKimomJFL0dkstCF3Em6yrybyGmGWE0NYbRI689pTv7puyQNjw-CWeCzx1OyW0q-jJ9SOmekXry-5edoqYv0ohLyB6TXkIM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PEPTIDESTER%2C+VERFAHREN+ZUR+HERSTELLUNG+DERSELBEN+UND+DIESE+ENTHALTENDE+ARZNEIMITTEL+BEZIEHUNGSWEISE+DIAGNOSTICA&rft.inventor=SZPORNY%2C+LASZLO&rft.inventor=KARPATI%2C+EGON&rft.inventor=NYEKI%2C+OLGA&rft.inventor=KISFALUDY%2C+LAJOS&rft.date=1985-06-15&rft.externalDBID=T1&rft.externalDocID=ATE13740TT1